New Insights Into Intellectual Disability Caused by Mutations in a Chromatin Regulator by Brookes, E
EBioMedicine 6 (2016) 2–3
Contents lists available at ScienceDirect
EBioMedicine
j ourna l homepage: www.eb iomed ic ine.comIn FocusNew Insights Into Intellectual Disability Caused by Mutations in a
Chromatin RegulatorEmily Brookes
MRC Laboratory of Molecular Cell Biology, University College London, Gower Street, London WC1E 6BT, United KingdomE-mail address: e.brookes@ucl.ac.uk.
http://dx.doi.org/10.1016/j.ebiom.2016.04.001
2352-3964/© 2016 The Author. Published by Elsevier B.Va r t i c l e i n f o defects in learning andmemory. The gross architecture of the brain wasAvailable online 4 April 2016
unaffected in Kdm5c-knockout mice, but abnormal neuronal morpholo-
gy was noted in speciﬁc regions related to aggression (the basolateralIntellectual disability (ID) is deﬁned as limitations in both mental spinemorphology have been identiﬁed in human post-mortem samplescapacity and adaptive behaviour, and affects 2–3% of the population
worldwide. A subset of ID, thought to be 5–10% of ID in males, is caused
by mutations on the X chromosome (X-linked intellectual disability;
XLID). Improvements in sequencing technologies have enabled the
association of numerous genetic variants with ID, but the underlying
etiology remains poorly understood, and diagnosis and treatment re-
main limited. Mutations in KDM5C (also known as JARID1C and SMCX)
wereﬁrst found in XLID patients in 2005 (Jensen et al., 2005). Additional
KDM5C mutations were subsequently identiﬁed and they are now
thought to account for 1–4% of X-linked ID. This is a substantial propor-
tion; in comparison, Fragile-X syndrome is the most common cause of
XLID and accounts for less than 10%. KDM5C-linked ID patients (OMIM
300534) often display short stature (~60% patients) and aggressive
behaviour (~30% patients) in addition to mild to severe ID.
KDM5C encodes a histone demethylase speciﬁc for histone 3 lysine 4
di- and tri-methylation (H3K4me2/3; Iwase et al., 2007). Histone pro-
teins organize the genome, with DNA wrapping around histone
octamers to form the basic unit of chromatin. Post-translational modiﬁ-
cation of histones inﬂuences chromosome compaction and provides
binding sites for speciﬁc proteins, thereby regulating nuclear processes.
Distinct histone modiﬁcations correlate with different transcriptional
states; the KDM5C target H3K4me3 marks active promoters. Patient
KDM5C mutations lower protein levels through nonsense-mediated
decay or diminished protein stability, and missense mutations reduce
demethylase activity (Brookes et al., 2015). This suggests a loss-of-
function disease mechanism, but the cellular and molecular changes
are not fully understood.
In a recent study, Yang Shi and colleagues illuminatedKDM5C-linked
ID through generating and characterising a Kdm5c-knockout mouse
(Iwase et al., 2016). Importantly, behavioural tests conﬁrm that the
mouse is a good model for the disorder, with Kdm5c-knockout mice
showing heightened aggression, reduced anxiety, social aversion, and. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).f
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,amygala; BLA) and learning (BLA and cortex). Dendritic spine density
was affected in both of these regions, whilst dendritic arborisation
was reduced in the BLA (Fig. 1). Defects in dendritic branching and
of different neurological disorders (Kulkarni and Firestein, 2012), sug-
gesting that these deﬁcits may be a morphological correlate o
KDM5C-linked ID.
To understand how loss of a histone demethylase results in the cel-
lular defects observed, the authors examined genome-wide changes in
gene expression in Kdm5c-knockout amygdala and cortex (Iwase
et al., 2016). Multiple pathwaysweremisregulated, including pathways
important for neurological development and function. Exploration o
the contribution of each altered gene/pathway to the behavioura
phenotypes should provide insight into potential therapeutic targets
for patients. Interestingly, in addition to inﬂuencing transcription
KDM5C has been shown to regulate DNA replication (Rondinelli et al.
2015). Although neurons are post-mitotic, this could have important
implications during development, when ID is thought to arise.
To explore the mechanisms of Kdm5c transcriptional regulation
Iwase et al. used primary neuronal cultures from wildtype and Kdm5c-
KO littermates (Iwase et al., 2016). Kdm5c binding sites across the ge-
nome were enriched for CpG islands and high levels of H3K4me3. This
ﬁnding is consistent with a recent study showing that Drosophila Lid
the Kdm5 family ortholog, recognises H3K4me2/3 through its PHD
(plant homeodomain) ﬁnger, and co-localises with the mark genome-
wide (Liu and Secombe, 2015). Intriguingly, only the Kdm5c-bound
genes with the lowest expression levels show signiﬁcant expression
changes in Kdm5c-knockout neurons (Iwase et al., 2016). Chromatin
modiﬁers are often postulated to ‘ﬁne-tune’ expression, and this may
explain why robustly transcribed genes show little alteration following
its removal. Genes with altered expression levels in Kdm5c-knockout
neurons predominantly show up-regulation and enhanced H3K4me3
in keeping with Kdm5c acting as a repressor through removal of an ac-
tive chromatin modiﬁcation (Fig. 1). A previous study of Kdm5c-
knockout embryonic stem cells similarly found that Kdm5c acts at pro-
moters to repress genes, but also suggested that Kdm5c is able to acti-
vate genes through the same demethylase activity at enhancers
(Outchkourov et al., 2013). It remains to be seenwhether enhancer reg-
ulation contributes to KDM5C patient symptoms; down-regulated
Fig. 1.Model for howmutations in chromatin regulator genes cause disease, exempliﬁed byKDM5Cmutations.Mutations in chromatin regulator genes affect protein level or activity, such
as reduced histone demethylase (HDM) activity of mutant KDM5C. This results in alterations in chromatin conformation at target genes, such as increased H3K4me3 at KDM5C target
promoters. Resultant changes in transcription induce cellular phenotypes, to which neurons seem particularly susceptible, leading to disease symptoms.
3E. Brookes / EBioMedicine 6 (2016) 2–3genes were identiﬁed in Kdm5c-knockout brain and cultured neurons
(Iwase et al., 2016) but the mechanisms were not examined.
One intriguing facet of KDM5C-linked XLID is that whilst the
mutations are germline and therefore present in all cells, the
most prominent symptoms are neurological. Changes in gene ex-
pression (Jensen et al., 2010) have also been were identiﬁed in
blood samples from patients with KDM5C mutations (Jensen et al.,
2010). This suggests that changes in chromatin modiﬁcation may
occur in many tissues without eliciting a phenotype, whereas the
highly complex and more recently evolved central nervous system
is susceptible. This observation is by no means unique to KDM5C
mutations; germline mutations in many chromatin modiﬁers give
rise to disorders with a neurological component. Of note, chroma-
tin changes in more easily accessible tissues may be useful as mo-
lecular markers for diagnosis and treatment. This is exempliﬁed
in a recent study of Sotos Syndrome, a syndromic ID disorder
caused by mutations in the histone methyltransferase NSD1,
which determined a signature of DNA methylation in peripheral
blood that could be used to diagnose sufferers (Choufani et al.,
2015).
Mutations in genes encoding chromatin regulators are increasingly
being recognized as an important contributor to neurological disorders
including ID, autism spectrum disorders and schizophrenia. Further-
more, changes to chromatin can also be instigated by the environment
and may contribute to disease susceptibility and prognosis. Thus,
chromatinmodiﬁcations should be considered as promising biomarkers
and potential therapeutic targets. Good mouse models, such as the
Kdm5c-knockout mice described here (Iwase et al., 2016), provide
valuable tools to advance clinical practice.References
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